What an ACL tear actually does to your knee joint

Losing an ACL is, at its core, a mechanical problem. The ligament's primary job is to prevent the tibia from sliding forward on the femur — it contributes roughly 85% of the restraining force against that movement. Once it tears, that restraint disappears entirely, and no amount of muscle conditioning fully replaces it.

The practical consequence shows up with every step: ACL-deficient knees demonstrate approximately 3–5 mm more anterior tibial translation than the uninjured side during weight-bearing. That gap sounds small, but it is enough to shift load onto cartilage surfaces that evolved to receive force only within a controlled, predictable arc. The damage does not come from a single dramatic misstep. It accumulates through hundreds of ordinary movements — walking on uneven ground, pivoting on a step, absorbing a modest impact — each one replaying the same abnormal shear and compressive pattern across joint surfaces that cannot escape it.

This is where the avascular nature of articular cartilage becomes the central problem. Unlike bone or muscle, cartilage has no blood supply. It cannot mount a repair response; it cannot regenerate once worn. Each loading cycle that exceeds what healthy joint mechanics would permit removes a little more of a material the body has no means to replace. The process, once started, does not reverse on its own.

Why the damage compounds rather than stabilises

The ACL contains mechanoreceptors — sensory nerve endings that relay continuous positional data to the neuromuscular system. Their loss after a complete tear disrupts the reflex arc that normally pre-tenses the quadriceps a fraction of a second before heel strike. The muscle group that should absorb and distribute load arrives late, or not at all, leaving cartilage to absorb forces it was not designed to meet alone.

This feeds directly into a well-documented pattern of vastus medialis oblique (VMO) atrophy. The VMO — the teardrop-shaped portion of the quadriceps that governs medial patellar tracking and knee stability — is consistently one of the first muscles to weaken after ACL injury. As it diminishes, so does the dynamic stabilisation that partly compensates for the absent ligament, and each ordinary weight-bearing step reapplies the same abnormal stress described in the previous section.

Over months, the nervous system adapts — but not helpfully. Patients typically develop a 'quadriceps avoidance' gait, characterised by reduced knee flexion at heel strike, which shifts load towards joint surfaces less equipped to handle it. Altered trunk lean compounds this further. These compensatory patterns are not solutions; they are the body protecting itself at the cost of distributing stress abnormally, and they tend to entrench rather than resolve.

This process commonly starts from an already compromised baseline. In approximately 50% of ACL tears, the meniscus, cartilage, or surrounding ligaments are concurrently damaged at the point of injury — meaning the protective architecture that healthy cartilage depends on is already partially absent before the instability cascade has properly begun.

Post-traumatic osteoarthritis: what the long-term data shows

The population-level numbers are striking. Post-traumatic osteoarthritis (PTOA) is reported in 18–71% of patients over the long term following an ACL tear — a range that reflects genuine variation in how studies define OA and how long they follow participants, rather than uncertainty about whether it occurs. Shorter studies using strict symptomatic criteria tend to sit at the lower end; longer studies using radiographic criteria cluster towards the top.

The trajectory becomes clearer when the data is broken down by timepoint. Around 35% of ACL injury patients develop symptomatic PTOA within 10 years. That figure rises to approximately 50% within 12–14 years for those who have undergone reconstruction, and over a 20-year horizon roughly 73% of patients show radiographic signs of knee OA — compared with a general adult prevalence (in those aged 45 and over) of 19–28%. That gap is substantial, and it persists across surgical and non-surgical cohorts.

One factor that consistently accelerates the trajectory is meniscus involvement. In younger patients with medial meniscal ramp lesions undergoing ACL reconstruction, over half — 53% in one surgical series — had concurrent articular cartilage injuries at the time of operation, predominantly at the medial femoral condyle. A compromised meniscus removes the shock-absorption buffer that offloads cartilage; the combined effect on long-term OA risk is additive.

A distinction worth holding onto: radiographic OA and symptomatic OA are not the same thing. Imaging changes — narrowed joint space, early osteophyte formation — can be present in patients with no meaningful functional limitation, and a scan finding alone does not determine quality of life. These figures describe population-level probabilities; they are not individual prognoses.

Surgery vs rehabilitation: what the evidence actually settles

Both clinical routes — surgery and rehabilitation — share the same mechanistic goal: eliminate the instability that drives cartilage loss. Which route achieves that better, and for whom, is a question the current evidence does not resolve.

Systematic review-level evidence does not establish ACL reconstruction as superior to conservative management in preventing PTOA. Convincing evidence for surgical superiority remains lacking, and PTOA risk reflects multiple interacting factors — structural, biological, mechanical, and neuromuscular — rather than simply whether the ligament is reconstructed.

There is a further complication. Some studies report more early cartilage changes and greater radiographic OA signs within two years of surgery than with rehabilitation alone, though whether this translates into worse symptomatic outcomes is unclear. The early post-surgical inflammatory environment may itself generate transient cartilage stress before any protective benefit accrues.

A 2024 mouse model provides the clearest mechanistic confirmation available. Surgical restabilisation after ACL rupture reduced OA scores by 78%, synovitis by 37%, and osteophyte formation by 97% compared with untreated controls — establishing that ongoing instability, not merely the initial injury event, is the primary engine of cartilage deterioration. This is animal evidence, and it does not settle which human pathway better eliminates that instability in practice: the restabilisation in that model was absolute, which no clinical intervention guarantees.

In practice, the decision hinges on age, activity demands, frequency of giving-way episodes, and joint status on imaging. For patients with infrequent instability and moderate activity demands, neuromuscular rehabilitation has a legitimate evidence base — it is not simply a fallback for those unsuitable for surgery. For those with recurrent giving-way or high-load sport goals, reconstruction more reliably removes the mechanical conditions that drive cartilage loss over time.

The honest structural limitation: no randomised controlled trial has followed surgical and conservative cohorts beyond ten years with PTOA as the primary outcome. That gap means this question stays genuinely open, and why individual specialist assessment — rather than any blanket recommendation — remains the appropriate basis for a decision.

Early cartilage monitoring and the intervention window

Cartilage damage visible on standard MRI already reflects structural change that has occurred, not change that might be prevented. The clinical interest in quantitative MRI techniques — specifically T1ρ and T2 mapping — lies in their ability to detect compositional shifts in cartilage before those structural changes appear on conventional imaging.

T1ρ and T2 sequences measure water content and collagen integrity within the cartilage matrix at a biochemical level. In published research, measurements taken within one year of ACL reconstruction predicted which patients would develop PTOA and worse pain outcomes at ten years; elevated T1ρ and T2 values in the medial femoral condyle at baseline were also associated with subsequent patellofemoral cartilage lesion progression. That predictive span is what gives the first post-injury year its clinical weight.

For patients identified as being on a high-risk trajectory, early detection opens management options: tighter load control, targeted neuromuscular rehabilitation to reduce compensatory joint stress, or biologic support such as intra-articular injection therapy. The data shows predictive power; it does not yet confirm that intervening at this stage changes long-term outcomes with certainty. Even so, waiting for symptoms to declare themselves structurally forfeits whatever narrow margin exists.

The practical constraint is access. Quantitative MRI protocols require specialist sequences and interpretation that are not part of routine clinical imaging. Determining which patients warrant that level of assessment — based on injury pattern, co-injury risk, and activity demands — is part of what a structured post-injury specialist review should establish.

When to seek specialist assessment

Several patterns warrant specialist review rather than watchful waiting. Giving-way episodes — even occasional ones — are not a symptom to manage around: each represents an episode of abnormal tibial translation loading unprotected cartilage surfaces. Persistent joint swelling beyond a few weeks, or pain that limits ordinary daily activity such as climbing stairs or walking at pace, are equally clear prompts to escalate beyond GP or physiotherapy input.

Specialist assessment at this level goes beyond confirming the ACL tear — that is often already established. The clinical priorities are characterising rotational instability severity through pivot-shift and Lachman testing, identifying concurrent meniscus or cartilage damage, and situating those findings against the patient's activity demands and goals. Standard MRI contributes to that picture; where early biochemical cartilage changes are suspected, the quantitative sequences described in the preceding section can add meaningful predictive information without the need to re-explain them here.

Timing carries real weight because cartilage loss does not reverse. The joint-preservation window is finite, which means early referral — before repeated giving-way episodes accumulate further damage — is the decision with the greatest leverage.

Patients who have already undergone ACL reconstruction but notice ongoing swelling, stiffness, or unexplained pain should not assume this reflects normal post-surgical change. Cartilage monitoring after reconstruction is a distinct clinical need, not an extension of ligament recovery.

For patients in London, a specialist assessment of this kind can be arranged through londoncartilage.com.

1. [1] Anterior cruciate ligament. https://en.wikipedia.org/?curid=578923 https://en.wikipedia.org/?curid=578923
2. [2] Quantitative MRI of Medial Tibial Cartilage at One Year after ACL Reconstruction can Predict PTOA at 10 Years. (2025). https://doi.org/10.1177/2325967125S00296 https://doi.org/10.1177/2325967125S00296
3. [3] Anterior cruciate ligament injury. https://en.wikipedia.org/?curid=5811552 https://en.wikipedia.org/?curid=5811552
4. [4] Articular Cartilage Injuries in Pediatric and Adolescent Patients Undergoing Medial Meniscal Ramp Lesion Repair During Primary ACL Reconstruction. (2025). https://doi.org/10.1177/03635465251366440 https://doi.org/10.1177/03635465251366440
5. [5] Surgical restabilization reduces the progression of post-traumatic osteoarthritis initiated by ACL rupture in mice. (2024). https://doi.org/10.1016/j.joca.2024.04.013 https://doi.org/10.1016/j.joca.2024.04.013
6. [6] Post-traumatic osteoarthritis following ACL injury. (2020). https://doi.org/10.1186/s13075-020-02156-5 https://doi.org/10.1186/s13075-020-02156-5
7. [7] Baseline cartilage T1ρ and T2 predicted patellofemoral joint cartilage lesion progression after ACL reconstruction. (2022). https://doi.org/10.1002/jor.25473 https://doi.org/10.1002/jor.25473